share_log

Expert Outlook: Metagenomi Through The Eyes Of 4 Analysts

Expert Outlook: Metagenomi Through The Eyes Of 4 Analysts

專家展望:從四位分析師的視角看Metagenomi
Benzinga ·  12/10 23:00
In the latest quarter, 4 analysts provided ratings for Metagenomi (NASDAQ:MGX), showcasing a mix of bullish and bearish perspectives.
在最近的季度中,有4位分析師對Metagenomi(納斯達克:MGX)進行了評級,展現出看好和看淡的觀點交織。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們近期的評級,展示了過去30天內情緒的變化,並與之前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $10.75, a high estimate of $15.00, and a low estimate of $7.00. Surpassing the previous average price target of $9.00, the current average has increased by 19.44%.
分析師通過對12個月價格目標的評估提供更深入的見解,揭示平均目標爲10.75美元,最高估計爲15.00美元,最低估計爲7.00美元。當前的平均值超過了之前的平均價格目標9.00美元,增加了19.44%。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級:更深入的了解
The standing of Metagenomi among financial experts is revealed through an in-depth exploration of...
通過對最近分析師行爲的深入探索...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論